EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer

Liang Zhao, Yizhen Pang, Long Sun, Qin Lin, Hua Wu, Haojun Chen

PET Clinics · 2023

DOI: 10.1016/j.cpet.2023.02.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2023. Verfasst von Liang Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, X…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Provincial Natural Science Foundation, Science Fund for Distinguished Young Scholars of Guangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiolabeled fibroblast activation protein inhibitor (FAPI) has been introduced as a promising PET tracer for imaging of pancreatic cancer. To date, FAPI PET/computed tomography (CT) has generally but not universally yielded higher radiotracer uptake and tumor-to-background contrast than 18F-fluorodeoxyglucose PET/CT in primary tumors, involved lymph nodes, and visceral metastases. It may also be useful for the evaluation of the tumor response to chemotherapy. However, increased FAPI uptake may be observed in benign conditions, including pancreatitis, pancreatic tuberculosis, IgG4-related disease, and serous cystadenoma, and therefore, clinical, radiological, and pathological correlations are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyPancreatic NeoplasmsHumansPositron-Emission TomographyFibroblastsGallium RadioisotopesFluorodeoxyglucose F18

Stichwörter der Autor:innen

FAPIFDGOncologic managementPETPancreatic cancer

Substanzen

Gallium RadioisotopesFluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen 361003, Chi…
  • Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, 55 Zhenhai Road, Siming Dis…

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Natural Science Foundation
  • Science Fund for Distinguished Young Scholars of Guangxi Province

Zitieren

APA

Zhao, L., Pang, Y., Sun, L., Lin, Q., Wu, H., & Chen, H. (2023). Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. PET Clinics. https://doi.org/10.1016/j.cpet.2023.02.001

Vancouver

Zhao L, Pang Y, Sun L, Lin Q, Wu H, Chen H. Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer. PET Clinics. 2023. doi:10.1016/j.cpet.2023.02.001

BibTeX
@article{Zhao2023,
  author = {Zhao, Liang and Pang, Yizhen and Sun, Long and Lin, Qin and Wu, Hua and Chen, Haojun},
  title = {Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer},
  journal = {PET Clinics},
  year = {2023},
  doi = {10.1016/j.cpet.2023.02.001}
}
Kostenlos starten →